BioPharma Credit PLC (BPCR) — Cash Flow Reinvestment Rate
BioPharma Credit PLC (BPCR) has a Cash Flow Reinvestment Rate of 0.00x as of June 2025, reinvesting $0.00 (capex $0.00 ) from operating cash flow of $33.76 Million. See BioPharma Credit PLC free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
BioPharma Credit PLC Cash Flow Reinvestment Rate (2017–2024)
Historical reinvestment intensity for BioPharma Credit PLC across 8 annual periods. For the full cash flow conversion analysis, see BioPharma Credit PLC (BPCR) cash flow conversion.
Annual Cash Flow Reinvestment Rate for BioPharma Credit PLC (2017–2024)
Year-by-year capital reinvestment analysis for BioPharma Credit PLC. See BioPharma Credit PLC (BPCR) financial flexibility to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.35x | $39.07 Million | $111.91 Million | $0.00 | ▲ +2497.0% |
| 2023 | 0.01x | $1.66 Million | $123.18 Million | $0.00 | ▼ -94.9% |
| 2022 | 0.26x | $48.19 Million | $184.28 Million | $0.00 | ▼ -73.4% |
| 2021 | 0.98x | $94.82 Million | $96.44 Million | $0.00 | ▲ +20.3% |
| 2020 | 0.82x | $47.47 Million | $58.07 Million | $0.00 | ▲ +7.2% |
| 2019 | 0.76x | $100.30 Million | $131.52 Million | $0.00 | ▼ -88.3% |
| 2018 | 6.51x | $436.99 Million | $67.14 Million | $0.00 | ▼ -57.7% |
| 2017 | 15.38x | $354.74 Million | $23.07 Million | $0.00 | — |